{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:40:34Z","timestamp":1779910834597,"version":"3.53.1"},"reference-count":22,"publisher":"Royal College of Psychiatrists","issue":"6","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"unspecified","delay-in-days":7521,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1997,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Studies performed with schizophrenic adults who were resistant to classical neuroleptics showed improvement in 30% of the patients when treated with clozapine. Very early onset schizophrenic patients benefit only partially from conventional antipsychotics and are at increased risk of developing extrapyramidal symptoms; clozapine may offer an alternative treatment for these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Eleven neuroleptic-resistant children (&lt; 13 years) with schizophrenia were treated with clozapine. Improvement was monitored during the first 16 weeks using the Brief Psychiatric Rating Scale, Positive and Negative Syndrome Scale and Clinical Global Impression. The mean clozapine dosage was 227.3 (s.d. 34.4) mg\/day at the end of the 16 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was an overall statistically significant reduction in all parameters, especially positive symptoms, implying a favourable outcome. Most of the improvement occurred during the first 6 to 8 weeks. The major side-effects were somnolence and drooling (no agranulocytosis).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Clozapine may be a promising drug for the treatment of resistant childhood-onset schizophrenia.<\/jats:p><\/jats:sec>","DOI":"10.1192\/bjp.170.6.507","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T05:36:56Z","timestamp":1224049016000},"page":"507-510","source":"Crossref","is-referenced-by-count":57,"title":["An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia"],"prefix":"10.1192","volume":"170","author":[{"given":"M.","family":"Turetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mozes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Chernauzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yoran-Hegesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Wittenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"S0007125000258972_ref8","volume-title":"ECDEV Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"S0007125000258972_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"S0007125000258972_ref15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0193-953X(18)30261-2","volume":"15","author":"McClellan","year":"1992","journal-title":"Schizophrenia Psychiatric Clinics of North America"},{"key":"S0007125000258972_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199401000-00010"},{"key":"S0007125000258972_ref9","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199324020-00005"},{"key":"S0007125000258972_ref3","first-page":"113","volume-title":"Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders","author":"Campbell","year":"1985"},{"key":"S0007125000258972_ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199201000-00024"},{"key":"S0007125000258972_ref12","first-page":"96","volume-title":"Pathways of Growth - Essentials of Child Psychiatry","volume":"2","author":"King","year":"1991"},{"key":"S0007125000258972_ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950150005001"},{"key":"S0007125000258972_ref19","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"S0007125000258972_ref1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1987"},{"key":"S0007125000258972_ref16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0193-953X(18)30179-5","article-title":"New drugs for the treatment of schizophrenia","volume":"16","author":"Meitzer","year":"1993","journal-title":"Psychiatric Clinics of North America"},{"key":"S0007125000258972_ref22","first-page":"102","article-title":"Clozapine in tardive dyskinesia: observations from human and animal model studies","volume":"55","author":"Tamminga","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000258972_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1974.tb09706.x"},{"key":"S0007125000258972_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/17.2.247"},{"key":"S0007125000258972_ref18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/S0007125000296931","article-title":"Clinical management of clozapine patients in relation to efficacy and side effects","volume":"160","author":"Naber","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"S0007125000258972_ref13","first-page":"271","article-title":"Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs","volume":"49","author":"Lieberman","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000258972_ref4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/S0007125000296888","article-title":"PET analysis indicates atypical central dopamine receptor occupancy in clozapme-treated patients","volume":"160","author":"Farde","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"S0007125000258972_ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"S0007125000258972_ref5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00004583-199406000-00006","article-title":"An open trial of clozapine in 11 adolescents with childhood onset schizophrenia","volume":"33","author":"Frailer","year":"1994","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"S0007125000258972_ref20","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/20.4.727"},{"key":"S0007125000258972_ref14","first-page":"329","article-title":"Clozapine: guidelines for clinical management","volume":"50","author":"Lieberman","year":"1989","journal-title":"Journal of Clinical Psychiatry"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000258972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T20:56:59Z","timestamp":1557608219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000258972\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["S0007125000258972"],"URL":"https:\/\/doi.org\/10.1192\/bjp.170.6.507","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}